Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma
Day 2 Packaging & Device Innovation Stage
07/10/2026 16:15 - 17:00pm
Contributors
Clare Beddoes : Head of Drug Delivery - Cambridge Design Partnership
Sara Stewart : Communications Specialist
Søren Skov : Senior Human Factors Engineer - Roche
Robert Lindner : Global Platform Leader Biologics - Datwyler
Noah Flajsing : Associate Director Marketing - BD MEDICAL - PHARMACEUTICAL SYSTEMS
The shift toward high-concentration biologics and large-volume subcutaneous injections has created a fundamental split in the industry. While some manufacturers champion on-body delivery systems for patient convenience, others argue that patients reject wearable devices in favor of handheld auto-injectors—even if the injection takes several minutes. This session examines the evidence, cost implications, and real-world patient preferences driving device selection for volumes exceeding 2mL.